Correlation Between De Rucci and Wuhan Hvsen

Can any of the company-specific risk be diversified away by investing in both De Rucci and Wuhan Hvsen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining De Rucci and Wuhan Hvsen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between De Rucci Healthy and Wuhan Hvsen Biotechnology, you can compare the effects of market volatilities on De Rucci and Wuhan Hvsen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in De Rucci with a short position of Wuhan Hvsen. Check out your portfolio center. Please also check ongoing floating volatility patterns of De Rucci and Wuhan Hvsen.

Diversification Opportunities for De Rucci and Wuhan Hvsen

-0.45

Correlation Coefficient

De Rucci  Wuhan Hvsen

Very good diversification

The 3 months correlation between 001323 and Wuhan is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding De Rucci Healthy and Wuhan Hvsen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wuhan Hvsen Biotechnology and De Rucci is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on De Rucci Healthy are associated (or correlated) with Wuhan Hvsen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wuhan Hvsen Biotechnology has no effect on the direction of De Rucci i.e., De Rucci and Wuhan Hvsen go up and down completely randomly.

Pair Corralation between De Rucci and Wuhan Hvsen

Assuming the 90 days trading horizon De Rucci Healthy is expected to under-perform the Wuhan Hvsen. But the stock apears to be less risky and, when comparing its historical volatility, De Rucci Healthy is 1.53 times less risky than Wuhan Hvsen. The stock trades about -0.09 of its potential returns per unit of risk. The Wuhan Hvsen Biotechnology is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1,074  in Wuhan Hvsen Biotechnology on December 24, 2024 and sell it today you would earn a total of  149.00  from holding Wuhan Hvsen Biotechnology or generate 13.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

De Rucci Healthy  vs.  Wuhan Hvsen Biotechnology

De Rucci Healthy

Risk-Adjusted Performance

Very Weak

Over the last 90 days De Rucci Healthy has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Wuhan Hvsen Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Wuhan Hvsen Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Wuhan Hvsen sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with De Rucci and Wuhan Hvsen

The main advantage of trading using opposite De Rucci and Wuhan Hvsen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if De Rucci position performs unexpectedly, Wuhan Hvsen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan Hvsen will offset losses from the drop in Wuhan Hvsen's long position.

The idea behind De Rucci Healthy and Wuhan Hvsen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.